Blog

i3 Consult : Life Cycle Analysis Services

i3 Consult has been operating its global, premier, affordable, innovative Life Cycle Analysis Services since 2002 to enable from small-capital to established healthcare, pharma or life science companies to meet their regulatory obligations yet maximize...

Read More »

i3 Consult Launches Business Operations in East Africa

  Healthcare investment In the East African region has grown year-on-year in the past decade. The opportunities in the region are enormous, with a regional capital demand for the sector beyond $10 billion. Although no...

Read More »

iClinical : The Minerva Chatbot

i3 Consult wishes to announce the arrival of a new product in the clinical trial service space by iClinical called Minerva, a Chatbot for pharmaceutical companies and patient engagement. The Minerva chatbot offers a new modality...

Read More »

The Role of Mobile Technology in Kenya Healthcare

In a report released last year by Statista [i], Kenya is the leading consumer of internet via use of smartphones in the world. This has been attributed to the country’s high level of smartphones penetration...

Read More »

Generic drugs or Branded drugs: Which is better?

Pharmaceutical companies still invest billions of dollars over several years in order to get their drug pipeline of product(s) approved, registered and patent protected to maximise profits from such brand ownership in a highly competitive...

Read More »

New i3 Consult Video

i3 Consult is proud to announce the promotion of its new premium strategic marketing, financial and operational management solutions package for healthcare, pharmaceutical and other life science organisations via the release of its You Tube...

Read More »